SUBSCRIBE
SUBSCRIBE

Astria Therapeutics

NEWS
Business
BioSpace Movers & Shakers: Astria, Apertura, CytoDyn, IN8bio & More Make Big Moves
New leaders and top executive roles were selected to guide biopharma and life science companies from Apertura Gene Therapy to CytoDyn, Vaccentis AG, Suvoda LLC, IN8bio and more.
July 14, 2022
 · 
9 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Genetown
Astria Therapeutics to Present at Upcoming 2022 Jefferies London Healthcare Conference
November 9, 2022
 · 
1 min read
Genetown
Astria Therapeutics to Present STAR-0215 Modeling and Simulation Data at the 2022 American College of Allergy, Asthma and Immunology Annual Meeting
November 7, 2022
 · 
5 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 02, 2022
November 2, 2022
 · 
1 min read
Genetown
Astria Therapeutics to Host Virtual R&D Day: Update on STAR-0215 and Its Clinical Development
September 16, 2022
 · 
1 min read
Genetown
Astria Therapeutics to Present at Upcoming Investment Conferences in September 2022
September 6, 2022
 · 
1 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sep 02, 2022
September 2, 2022
 · 
1 min read
Business
Astria Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
August 9, 2022
 · 
10 min read
Drug Development
Astria Therapeutics Announces Initiation of Phase 1a Trial of STAR-0215, a Monoclonal Antibody Inhibitor of Plasma Kallikrein for Treatment of Hereditary Angioedema
August 4, 2022
 · 
6 min read
Genetown
Astria Therapeutics to Present at Upcoming Wedbush PacGrow Healthcare Conference 2022
August 3, 2022
 · 
1 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Aug 02, 2022
August 2, 2022
 · 
2 min read
Load More